All news
  • ARPM: old song about the main thing or again about labeling

    The Association of Russian Pharmaceutical Manufacturers is extremely concerned about the industry’s low current readiness for the industrial exploitation of a drug labeling system from January 1, 2020, and for drugs of group 7 high-cost nosologies from October 1 of this year. This condition will inevitably lead to destabilization of drug supply in the Russian Federation.

  • Protection of an expensive molecule or what will change in the generic market of Russia

    The human body is subject to many diseases, so without drugs it simply can not cope. The health of people, the improvement of the quality of life and its duration are the main goals of pharmaceutical companies. The development, testing, production and marketing of innovative products is aimed at improving the quality and longevity of the population.

  • The “velvet” season on the amber coast promises to be hot!

    The partnership session "Medicines of Russia - to interdisciplinary dialogue" will be held on September 24 as part of the annual GMP conference in Svetlogorsk. The Association of Russian Pharmaceutical Manufacturers, together with the Ministry of Health of the Kaliningrad Region, this year chose a new format of communication between the professional pharmaceutical community and government authorities. This will allow to discuss topical issues of the pharmaceutical industry, go into details and find the best ways to achieve the stated goals.

  • Marking: a new stage - old problems or promises are not fulfilled again!

    In Russia, a new phase of mandatory labeling of drugs begins. From July 1 to July 8, manufacturers, distributors, pharmacies are required to register in the Drug Movement Monitoring (DMM) system to work with high-cost nosologies.

  • ARPM: It is time to think about the disposal of medicines at the household level

    Today, the Russian pharmaceutical market is one of the most dynamic and fast-growing in the world. In this area, there is an active import substitution. A significant part of the drugs produced in Russia can be attributed to high-tech products. This success, of course, is associated with the implementation of the Pharma-2020 strategy.

  • ARPM: a market in exchange for investment

    The Association of Russian Pharmaceutical Manufacturers participates in the largest pharmaceutical exhibition in Asia, CPhI & ICSE China. One of the main goals of the trip is to support international scientific research and clinical trials in the field of pharmaceuticals.

  • Pharmrace - ARPM - Yaroslavl pharmaceutical cluster a new stage of development

    On June 1, a meeting of federal and regional authorities with representatives of the industry and the scientific community was held in Yaroslavl as part of the All-Russian Pharmaceutical race. The round table was moderated by Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers.


All projects

Membership of ARFP in the Organizations

Russian Union of Industrialists
and Entrepreneurs (RSPP)

Chamber of Commerce and Industry (CCI)
of the Russian Federation

Awards of Association

Partners of association